Sino Medical Sciences Technology In Capital Reinvestment Ratio
Sino Medical Sciences Technology In capital reinvestment ratio. Sino Medical Sciences Technology In (688108) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.52 Million) in capital expenditures (CN¥6.63 Million). Check Sino Medical Sciences Technology In (688108) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sino Medical Sciences Technology In (2016–2025)
Capital reinvestment ratio of Sino Medical Sciences Technology In from 2016 to 2025. This chart tracks Sino Medical Sciences Technology In's Capital Reinvestment Ratio across 8 annual periods. Also explore 688108 net asset momentum to track the company's year-over-year net asset growth rate.
Sino Medical Sciences Technology In Capital Reinvestment Ratio by Year (2016–2025)
Sino Medical Sciences Technology In capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Sino Medical Sciences Technology In.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥161.87 Million | CN¥45.80 Million | ▼ -47.0% |
| 2024 | 0.53x | CN¥131.24 Million | CN¥70.02 Million | ▼ -55.2% |
| 2023 | 1.19x | CN¥56.84 Million | CN¥67.67 Million | ▼ -25.6% |
| 2020 | 1.60x | CN¥70.51 Million | CN¥112.78 Million | ▲ +22.2% |
| 2019 | 1.31x | CN¥137.61 Million | CN¥180.04 Million | ▲ +29.1% |
| 2018 | 1.01x | CN¥97.56 Million | CN¥98.87 Million | ▼ -6.5% |
| 2017 | 1.08x | CN¥70.32 Million | CN¥76.25 Million | ▲ +3.3% |
| 2016 | 1.05x | CN¥42.24 Million | CN¥44.32 Million | — |